Condition
Major Depression Moderate
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Recruiting2
Enrolling By Invitation1
Terminated1
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07740694RecruitingPrimary
EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT
NCT07503002Phase 1Not Yet RecruitingPrimary
Shortened LSD Intervention for Major Depressive Disorder
NCT07146269Not ApplicableEnrolling By InvitationPrimary
Virtual Reality-Augmented At-Home tDCS for Major Depression
NCT07140575Not ApplicableRecruitingPrimary
rTMS for Youth Inpatients With Depression
NCT03254342Terminated
MRS and Medication Response: A Pilot Study
Showing all 5 trials